Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1751 to 1800 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BARD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MSRA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01256\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.393\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01242\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.09\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0124\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCYT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ethanolamine-phosphate cytidylyltransferase (ec 2.7.7.14) (phosphorylethanolamine transferase) (ctp:phosphoethanolamine cytidylyltransferase). [source:swissprot;acc:q99447]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01238\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUVBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.086\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, skeletal muscle isoform (mlc1f) (a1 catalytic) (alkali). [source:swissprot;acc:p05976]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle b/ventricular isoform (mlc1sb) (alkali). [source:swissprot;acc:p08590]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle a isoform (mlc1sa) (alkali). [source:swissprot;acc:p14649]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1764\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, embryonic muscle/atrial isoform (pro1957). [source:swissprot;acc:p12829]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1765\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.369\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTHFD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c-1-tetrahydrofolate synthase, cytoplasmic (c1-thf synthase) [includes: methylenetetrahydrofolate dehydrogenase (ec 1.5.1.5); methenyltetrahydrofolate cyclohydrolase (ec 3.5.4.9); formyltetrahydrofolate synthetase (ec 6.3.4.3)]. [source:swissprot;acc:p11586]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.932\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01223\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL24\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l24 (l30). [source:swissprot;acc:p38663]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
198.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1768\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HSD17B4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 4 (ec 1.1.1.62) (17-beta-hsd 4) (17-beta-hydroxysteroid dehydrogenase 4). [source:swissprot;acc:p51659]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
187.534\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01219\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1769\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTAP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5'-methylthioadenosine phosphorylase (ec 2.4.2.28) (mta phosphorylase) (mtapase). [source:swissprot;acc:q13126]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1770\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 1 subunit (mu-adaptin 1) (adaptor protein complex ap-1 mu-1 subunit) (golgi adaptor ha1/ap1 adaptin mu-1 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 1) (clathrin coat assembly protein ap47) (clathrin coat associated protein ap47) (ap-mu chain family member mu1a). [source:swissprot;acc:q9bxs5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.082\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.778\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1771\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FTSJ1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative ribosomal rna methyltransferase 1 (ec 2.1.1.-) (rrna (uridine-2'-o-)-methyltransferase) (jm23 protein). [source:swissprot;acc:q9uet6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.016\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.734\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1772\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTBN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 2 (spectrin, non-erythroid beta chain 2) (beta-iii spectrin). [source:swissprot;acc:o15020]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.032\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
225.739\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01214\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1773\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTBN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
spectrin beta chain, brain 1 (spectrin, non-erythroid beta chain 1) (beta-ii spectrin) (fodrin beta chain). [source:swissprot;acc:q01082]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1774\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoacetylglucosamine mutase (ec 5.4.2.3) (pagm) (acetylglucosamine phosphomutase) (n-acetylglucosamine-phosphate mutase) (phosphoglucomutase 3). [source:swissprot;acc:o95394]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1775\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPTLC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine palmitoyltransferase 1 (ec 2.3.1.50) (long chain base biosynthesis protein 1) (lcb 1) (serine-palmitoyl-coa transferase 1) (spt 1) (spt1). [source:swissprot;acc:o15269]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.757\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.274\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1776\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.878\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.286\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0121\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1777\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-1 (homeobox protein pbx1) (homeobox protein prl). [source:swissprot;acc:p40424]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01206\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1780\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
germ cell-less. [source:refseq;acc:nm\_022471]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.335\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.877\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1781\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-3 (homeobox protein pbx3). [source:swissprot;acc:p40426]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.332\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.874\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1782\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C1orf179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hyporthetical protein mgc27169. [source:refseq;acc:nm\_176782]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1783\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis1. [source:swissprot;acc:o00470]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1784\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis2 (meis1-related protein 1). [source:swissprot;acc:o14770]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1785\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-2. [source:swissprot;acc:o95816]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1786\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor-2 (homeobox protein pbx2) (g17 protein). [source:swissprot;acc:p40425]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1787\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PBX4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-b-cell leukemia transcription factor 4. [source:refseq;acc:nm\_025245]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1788\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEIS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein meis3 (meis1-related protein 2) (fragment). [source:swissprot;acc:q99687]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1789\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RNASEH2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribonuclease hi large subunit (ec 3.1.26.-) (rnase hi large subunit) (rnase h(35)) (ribonuclease h2) (rnase h2). [source:swissprot;acc:o75792]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.539\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01205\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.349\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01197\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1791\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 3 (hu-antigen c) (huc) (paraneoplastic cerebellar degeneration-associated antigen) (paraneoplastic limbic encephalitis antigen 21). [source:swissprot;acc:q14576]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.866\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.295\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01194\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1792\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 4 (paraneoplastic encephalomyelitis antigen hud) (hu-antigen d). [source:swissprot;acc:p26378]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.199\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01193\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1793\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME2P1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative nucleoside diphosphate kinase (ec 2.7.4.6) (ndk) (ndp kinase). [source:swissprot;acc:o60361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.823\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoside diphosphate kinase b (ec 2.7.4.6) (ndk b) (ndp kinase b) (nm23-h2) (c-myc purine-binding transcription factor puf). [source:swissprot;acc:p22392]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.138\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.861\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1795\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 2 (hu-antigen b) (hub) (elav-like neuronal protein 1) (nervous system-specific rna binding protein hel-n1). [source:swissprot;acc:q12926]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.158\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1796\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOP2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.759\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.357\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1797\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NME2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleoside diphosphate kinase a (ec 2.7.4.6) (ndk a) (ndp kinase a) (tumor metastatic process-associated protein) (metastasis inhibition factor nm23) (nm23-h1). [source:swissprot;acc:p15531]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.111\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.834\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1798\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELAVL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elav-like protein 1 (hu-antigen r) (hur). [source:swissprot;acc:q15717]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.807\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.242\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1799\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.016\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.481\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01182\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1800\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DYRK1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1a (ec 2.7.1.-) (protein kinase minibrain homolog) (mnbh) (hp86) (dual specificity yak1-related kinase). [source:swissprot;acc:q13627]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.011\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1.0118\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/